03/29/2024
7:00 AM | Charles River Laboratories International (Filer)
| Form DEF 14A | |
03/29/2024
7:01 AM | Charles River Laboratories International (Filer)
| Form ARS | |
03/25/2024
5:48 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4/A | |
03/25/2024
5:52 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4/A | |
03/25/2024
5:58 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4/A | |
03/25/2024
6:00 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4/A | |
03/25/2024
4:49 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4/A | |
|
03/25/2024
4:52 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4/A | |
03/25/2024
4:55 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4/A | |
03/11/2024
3:42 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
1:34 PM | Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
3:54 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
11:47 AM | Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:37 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
2:14 PM | Charles River Laboratories International (Subject)
Creamer Victoria L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
11:42 AM | Charles River Laboratories International (Subject)
Parisotto Shannon M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:57 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
10:09 AM | Barbo William D (Reporting)
Charles River Laboratories International (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
4:28 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:32 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:37 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
10:02 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
8:19 AM | Charles River Laboratories International (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
7:31 PM | Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:35 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:14 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:34 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4/A | |
01/31/2024
4:26 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:28 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:31 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:23 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:59 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:03 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:34 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
01/16/2024
3:32 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
3:09 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:10 PM | Charles River Laboratories International (Subject)
Creamer Victoria L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:10 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
11:36 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
New crypto project uncovers 2,050% in 65 days (Ad) During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price.
I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. |
11/15/2023
8:23 AM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
7:31 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
11:14 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
8:06 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
3:23 PM | Charles River Laboratories International (Issuer)
WALLMAN RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
1:57 PM | Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
12:54 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023
8:09 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023
6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:37 PM | BlackRock Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
07/05/2023
2:29 PM | Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
2:31 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
9:22 AM | Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
5:10 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
3:17 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:18 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:21 PM | Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:24 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:27 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
12:38 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
3:55 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
2:24 PM | Charles River Laboratories International (Issuer)
Thompson Craig B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
2:27 PM | Charles River Laboratories International (Issuer)
WILSON VIRGINIA M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:48 PM | Charles River Laboratories International (Issuer)
REESE C RICHARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:26 PM | Charles River Laboratories International (Issuer)
Kochevar Deborah Turner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:30 PM | Charles River Laboratories International (Issuer)
Llado George Sr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:43 PM | Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:46 PM | Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:11 PM | Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
1:23 PM | BERTOLINI ROBERT J (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
1:18 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
3:02 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
1:42 PM | Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
1:49 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
1:20 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
1:51 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/11/2023
8:08 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
7:00 AM | Charles River Laboratories International (Filer)
| Form DEFA14A | |
